Targeting BRIX1 to Fight Cancer
Author Information
Author(s): Gan Yu, Hao Qian, Han Tao, Tong Jing, Yan Qingya, Zhong Hongguang, Gao Bo, Li Yanan, Xuan Zhisheng, Li Pengfei, Yao Litong, Xu Yingying, Jiang Yi‐Zhou, Shao Zhi‐Ming, Deng Jun, Chen Jiaxiang, Zhou Xiang
Primary Institution: Fudan University Shanghai Cancer Center
Hypothesis
Can targeting the nucleolar protein BRIX1 suppress cancer progression?
Conclusion
Targeting BRIX1 via engineered exosomes can effectively suppress colorectal cancer and enhance chemotherapy efficacy.
Supporting Evidence
- BRIX1 is a critical regulator of ribosome biogenesis and p53 activation.
- Depletion of BRIX1 induces nucleolar stress and activates p53, inhibiting tumor growth.
- Engineered exosomes loaded with siRNAs against BRIX1 significantly suppressed colorectal cancer growth.
- High levels of BRIX1 correlate with poor prognoses in breast and colorectal cancers.
Takeaway
Scientists found that a protein called BRIX1 helps cancer cells grow. By using special exosomes to deliver a treatment that targets BRIX1, they can slow down cancer growth.
Methodology
The study used bioinformatics analysis, cell-based assays, and engineered exosomes to investigate the role of BRIX1 in cancer.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website